[Characteristics of the changes in hypophyseal gonadotropic function during the treatment of uterine cancer patients].
D003131:Combined Modality Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism*; D008593:Menopause; D008875:Middle Aged; D010902:Pituitary Gland / Q000503:physiopathology*; D011184:Postoperative Period; D011300:Preoperative Care; D011388:Prolactin / Q000378:metabolism*; D014594:Uterine Neoplasms / Q000503:physiopathology* / Q000628:therapy
D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Osobennosti izmeneniia gonadotropnoĭ funktsii gipofiza v protsesse lecheniia bol'nykh rakom tela matki.